While patients who received docetaxel had a significant decrease in FACT-P-reported QoL between baseline and 3 months, no difference was noted between baseline and 12 months.
Researchers evaluated whether pacritinib would improve SVR and TSS compared with the best available therapy, including ruxolitinib.
Cancer Therapy Advisor asked Dr Gyawali, who coauthored a viewpoint just published in JAMA Oncology, to discuss the FDA’s approval of sunitinib, and whether it is an example of what he calls “regulatory capture” in medicine.
As the report covers only 3 of 1000 known BRCA variants, a negative result does not mean an individual is at a lower cancer risk.
Recommendations about population-wide PSA screening are mixed, with some studies suggesting that the potential benefits of early diagnosis are outweighed by overtreatment.
A variety of cognitive impairments are common in the elderly US population, with as many as 14% of individuals over 70 being affected by dementia.
Nut intake is associated with a reduced risk of type 2 diabetes and insulin resistance.
While checks were documented thoroughly in 3 centers, there were no internal standards for physician checks.
Researchers enrolled 66 patients with glioblastoma to evaluate the safety and efficacy of upfront temozolomide with bevacizumab.
Umbralisib has shown improved isoform selectivity over currently used PI3Kδ inhibitors.
